Jul 28, 2008 | Laboratory Management and Operations, Laboratory Pathology, Management & Operations
Although officials at Stanford Hospitals & Clinics decline to publicly discuss the pending sale of its laboratory outreach business, Laboratory Corporation of America (NYSE:LH), during a conference call with analysts executives last week, confirmed that the sale is imminent. “I can tell you that we signed a definitive agreement with Stanford in July to acquire their outreach business and we expect that to close on August 1st,” stated LabCorp President and CEO David King, in...